APA (7th ed.) Citation

K, P., V, F., A, S., I, K., DK, K., & SB, S. (2023). Necrostatin-1S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axis. Metabolic brain disease, 38(5), 1581. https://doi.org/10.1007/s11011-023-01185-8

Chicago Style (17th ed.) Citation

K, Preeti, Fernandes V, Sood A, Khan I, Khatri DK, and Singh SB. "Necrostatin-1S Mitigates Type-2 Diabetes-associated Cognitive Decrement and Lipotoxicity-induced Neuro-microglia Changes Through P-RIPK-RIPK3-p-MLKL Axis." Metabolic Brain Disease 38, no. 5 (2023): 1581. https://doi.org/10.1007/s11011-023-01185-8.

MLA (9th ed.) Citation

K, Preeti, et al. "Necrostatin-1S Mitigates Type-2 Diabetes-associated Cognitive Decrement and Lipotoxicity-induced Neuro-microglia Changes Through P-RIPK-RIPK3-p-MLKL Axis." Metabolic Brain Disease, vol. 38, no. 5, 2023, p. 1581, https://doi.org/10.1007/s11011-023-01185-8.